0001171843-14-002956.txt : 20140627 0001171843-14-002956.hdr.sgml : 20140627 20140624100036 ACCESSION NUMBER: 0001171843-14-002956 CONFORMED SUBMISSION TYPE: 25 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20140624 DATE AS OF CHANGE: 20140624 EFFECTIVENESS DATE: 20140624 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Capstone Therapeutics Corp. CENTRAL INDEX KEY: 0000887151 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 860585310 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 25 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33560 FILM NUMBER: 14936560 BUSINESS ADDRESS: STREET 1: 1275 WEST WASHINGTON STREET STREET 2: SUITE 101 CITY: TEMPE STATE: AZ ZIP: 85281 BUSINESS PHONE: 6022865520 MAIL ADDRESS: STREET 1: 1275 WEST WASHINGTON STREET STREET 2: SUITE 101 CITY: TEMPE STATE: AZ ZIP: 85281 FORMER COMPANY: FORMER CONFORMED NAME: ORTHOLOGIC CORP DATE OF NAME CHANGE: 19940211 25 1 f25_062414.htm FORM 25 f25_062414.htm
UNITED STATES
 SECURITIES AND EXCHANGE COMMISSION
 Washington, D.C.  20549
 
FORM 25
 
NOTIFICATION OF REMOVAL FROM LISTING AND/OR
REGISTRATION UNDER SECTION 12(b) OF THE
SECURITIES EXCHANGE ACT OF 1934.
 
Commission File Number 001-33560
 
  Issuer: CAPSTONE THERAPEUTICS CORP.
  Exchange: NASDAQ GLOBAL MARKET
 
(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
     
  Address: 1275 West Washington Street, Suite 104
    Tempe, Arizona 85281
  Telephone Number: (602) 286-5520
 
(Address, including zip code, and telephone number, including area code, of Issuer’s principal executive offices)
 
(Description of class of securities)
 
Rights to Purchase 1/100 of a Share of Series A Preferred Stock
 
Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
 
o 17 CFR 240.12d2-2(a)(1)
 
o 17 CFR 240.12d2-2(a)(2)
 
o 17 CFR 240.12d2-2(a)(3)
 
o 17 CFR 240.12d2-2(a)(4)

o Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange.1

x Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with the rules of the Exchange and the requirements of 17 CFR 240.12d2-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
 
June 24, 2014   /s/ John M. Holliman, III   Executive Chairman  
Date   Name   Title  
 
   
1 Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.